PMC:7796041 / 24572-26166
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
746 | 492-500 | Species | denotes | patients | Tax:9606 |
747 | 616-624 | Species | denotes | patients | Tax:9606 |
748 | 816-824 | Species | denotes | patients | Tax:9606 |
749 | 1265-1273 | Species | denotes | patients | Tax:9606 |
750 | 1386-1394 | Species | denotes | patients | Tax:9606 |
751 | 681-699 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
752 | 704-716 | Chemical | denotes | azithromycin | MESH:D017963 |
753 | 983-1001 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
754 | 1062-1074 | Chemical | denotes | azithromycin | MESH:D017963 |
755 | 1404-1407 | Chemical | denotes | QTc | |
756 | 33-43 | Disease | denotes | arrhythmia | MESH:D001145 |
757 | 81-89 | Disease | denotes | COVID-19 | MESH:C000657245 |
758 | 126-148 | Disease | denotes | cardiovascular disease | MESH:D002318 |
759 | 189-199 | Disease | denotes | arrhythmia | MESH:D001145 |
760 | 296-306 | Disease | denotes | arrhythmia | MESH:D001145 |
761 | 358-377 | Disease | denotes | infectious diseases | MESH:D003141 |
762 | 506-516 | Disease | denotes | arrhythmia | MESH:D001145 |
763 | 947-979 | Disease | denotes | prolongation of the QTc interval | MESH:D008133 |
764 | 1005-1013 | Disease | denotes | COVID-19 | MESH:C000657245 |
765 | 1124-1146 | Disease | denotes | ventricular arrhythmia | MESH:D001145 |
766 | 1201-1221 | Disease | denotes | torsades des pointes | MESH:D016171 |
767 | 1279-1302 | Disease | denotes | ventricular arrhythmias | MESH:D001145 |
768 | 1316-1338 | Disease | denotes | cardiovascular disease | MESH:D002318 |
769 | 1503-1526 | Disease | denotes | ventricular arrhythmias | MESH:D001145 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T177 | 33-43 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T178 | 126-148 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T179 | 189-199 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T180 | 296-306 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T181 | 506-516 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T182 | 1124-1146 | Phenotype | denotes | ventricular arrhythmia | http://purl.obolibrary.org/obo/HP_0004308 |
T183 | 1279-1302 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
T184 | 1316-1338 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T185 | 1503-1526 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T204 | 0-200 | Sentence | denotes | With respect to risk factors for arrhythmia incidence during hospitalization for COVID-19, we could identify age and previous cardiovascular disease as predictors for the occurrence of any arrhythmia. |
T205 | 201-383 | Sentence | denotes | These baseline characteristics have previously been shown to predispose for the development of arrhythmia in the general population without association with infectious diseases [24]. |
T206 | 384-488 | Sentence | denotes | Thus, they may reflect a subgroup of greater general susceptibility to additional proarrhythmic effects. |
T207 | 489-625 | Sentence | denotes | In patients with arrhythmia in our cohort, QTc duration was longer at admission, albeit within normal range in the majority of patients. |
T208 | 626-825 | Sentence | denotes | Dynamic changes of the QTc interval under therapy with hydroxychloroquine and azithromycin cannot be evaluated as repeated ECGs during hospital stay were not systematically available in all patients. |
T209 | 826-903 | Sentence | denotes | Thus, proarrhythmic effects of these drugs cannot be excluded in this cohort. |
T210 | 904-1091 | Sentence | denotes | Previous reports point towards significant prolongation of the QTc interval by hydroxychloroquine in COVID-19 which is even more enhanced in combination with azithromycin therapy [25,26]. |
T211 | 1092-1177 | Sentence | denotes | However, the rate of associated ventricular arrhythmia has been low in these studies. |
T212 | 1178-1430 | Sentence | denotes | Similarly, no typical “torsades des pointes” were seen in our cohort: in three of five patients with ventricular arrhythmias pre-existent cardiovascular disease was present, and only one of the remaining two patients received QTc-prolonging medication. |
T213 | 1431-1594 | Sentence | denotes | Thus, rather than induced by direct effects of administered medication, ventricular arrhythmias may have been due to other predisposing risk factors in our cohort. |